We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
The Effect of the Immunization Schedule and Antibody Levels (Anti-S) on the Risk of SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers in Northern Italy.
- Authors
Sansone, Emanuele; Collatuzzo, Giulia; Renzetti, Stefano; Ditano, Giorgia; Bonfanti, Carlo; Sala, Emma; Terlenghi, Luigina; Matteelli, Alberto; Abedini, Mahsa; Asafo, Shuffield Seyram; Boffetta, Paolo; De Palma, Giuseppe
- Abstract
Given their occupational risk profile, HCWs were the first to receive anti-SARS-CoV-2 vaccination. However, breakthrough infections remained common, mainly sustained by new SARS-CoV-2 variants of concern (VOCs) that rapidly spread one after another in Italy. Evidence suggests that the measured level of anti-SARS-CoV-2 antibodies does not clearly predict the level of protection conferred by either natural infection or vaccine-induced immunization, highlighting the need for further study on the diversity in susceptibility to SARS-CoV-2 infection. The present study aimed to characterize different risk profiles for SARS-CoV-2 infection in HCWs who had recently received the booster dose, and who were classified according to their immunization profile. The very small number of workers infected during the 8 months following the primary-cycle administration represents proof of the vaccine's effectiveness against non-omicron strains. The comparison among different immunization profiles showed that hybrid immunization (vaccine plus natural infection) elicits higher antibody levels. However, hybrid immunization does not always provide better protection against reinfection, thus suggesting that the immunization profile plays a major role as a virus–host interaction modifier. Despite the high resistance to the reinfection, the peri-booster infection had a not-neglectable infection rate (5.6%), this further reinforcing the importance of preventive measures.
- Subjects
NORTHERN Italy; ITALY; MEDICAL personnel; BREAKTHROUGH infections; SARS-CoV-2; BOOSTER vaccines; VACCINE effectiveness
- Publication
Vaccines, 2023, Vol 11, Issue 4, p746
- ISSN
2076-393X
- Publication type
Academic Journal
- DOI
10.3390/vaccines11040746